4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-060974
SVP & Chief Operating Officer sold 15,910 shares at $37.78 ($601,080)
- SVP & Chief Operating Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…